News


29th Sep 2009 - Ceremben Permit Approved

Daval Australia Limited has announced that the Australian Pesticides and Veterinary Medicines Authority has approved the promotion and sale to Australian veterinary surgeons of Ceremben, the parallel veterinary product to AIMSPRO, for the treatment of endotoxaemia in horses. (Permit Number PER11774 [pdf]). This results from a series of University led studies investigating the effects of Ceremben / AIMSPRO on inflammatory cytokine production under endotoxemic stress.

Latest news
    5th Nov 2009
AIMSPRO receives US orphan-drug designation for ALS
    29th Sep 2009
Ceremben Permit Approved
    22nd Jul 2009
Patent granted by the OAPI
Design by